🇺🇸 Summit Therapeutics Inc.
Forum topic · SMMT · Company page: financials, ownership and filings
Join the discussion on Summit Therapeutics Inc.
Loading…
Results announced on 4 November 2026
Summit Therapeutics Inc. announced results on 4 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $208 million.
Mutual funds: 152 funds hold $607 million
152 mutual funds in 2 countries hold shares of Summit Therapeutics Inc. worth $607 million, about 5.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 89 funds added shares and 39 sold; on balance they sold $11 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.